Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers
Clinical trial NCT01229371 · COMPLETED
Trial details
- NCT number
- NCT01229371
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-12-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.